Additional Reading and Resources

1. Costello K, et al. Recognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long term. Medscape J Med. 2008;10(9):225. http://www.ncbi.nlm.nih.gov/pubmed/19008986.

2. Derwenskus J, et al. Future treatment approaches to multiple sclerosis. Handb Clin Neurol. 2014;122:563-77. http://www.ncbi.nlm.nih.gov/pubmed/24507535.

3. Karussis D. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. J Autoimmun. 2014;48-49:134-42. http://www.ncbi.nlm.nih.gov/pubmed/24524923.

4. Lublin FD, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278-86. http://www.ncbi.nlm.nih.gov/pubmed/24871874.

5. Marcus JF, et al. Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis. Neurohospitalist. 2013;3(2):65-80. http://www.ncbi.nlm.nih.gov/pubmed/23983889.

6. Polman C, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302. http://www.ncbi.nlm.nih.gov/pubmed/21387374.

7. Simon JH. MRI outcomes in the diagnosis and disease course of multiple sclerosis. Handb Clin Neurol. 2014;122:405-25. http://www.ncbi.nlm.nih.gov/pubmed/24507528.

8. Sormani MP, et al. Can we measure long-term treatment effects in multiple sclerosis? Nat Rev Neurol. 2015;11(3):176-82.

9. Tanasescu R, et al. Advances in the treatment of relapsing-remitting multiple sclerosis. Biomed J. 2014;37(2):41-9. http://www.ncbi.nlm.nih.gov/pubmed/24732658.

10. Toosy A, et al. Symptomatic treatment and management of multiple sclerosis. Handb Clin Neurol. 2014;122:513-62. http://www.ncbi.nlm.nih.gov/pubmed/24507534.

11. Turner AP, et al. Injection anxiety remains a long-term barrier to medication adherence in multiple sclerosis. Rehabil Psychol. 2009;54:116–121. http://www.ncbi.nlm.nih.gov/pubmed/19618711.

12. Wong J, et al. Adherence to multiple sclerosis disease-modifying therapies in Ontario is low. Can J Neurol Sci. 2011;38:429-433. http://www.ncbi.nlm.nih.gov/pubmed/21515501.

Resources

American Academy of Neurology – https://www.aan.com

The Consortium of Multiple Sclerosis Centers – http://www.mscare.org

National Multiple Sclerosis Society – http://www.nationalmssociety.org

Multiple Sclerosis Association of America – http://www.mymsaa.org

Multiple Sclerosis Foundation – http://www.msfocus.org

National Institute of Neurological Disorders and Stroke – http://www.ninds.nih.gov/index.htm

Epidemiology

Explore

Treatments

Explore

Challenges in MS Management

Explore

Diagnosis and Symptoms

Explore

Pin It on Pinterest

Share This